Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Curr Opin Oncol

Retrieve available abstracts of 9 articles:
HTML format
Text format



Single Articles


    December 2016
  1. DUMMER R, Ramelyte E, Levesque M, Goldinger SM, et al
    Critical aspects to achieve a high-quality melanoma clinic.
    Curr Opin Oncol. 2016 Dec 23. doi: 10.1097/CCO.0000000000000357.
    PubMed     Text format     Abstract available


    March 2016
  2. SULLIVAN RJ
    The role of mitogen-activated protein targeting in melanoma beyond BRAFV600.
    Curr Opin Oncol. 2016;28:185-91.
    PubMed     Text format     Abstract available


    January 2016
  3. GOLDINGER SM, Panje C, Nathan P
    Treatment of melanoma brain metastases.
    Curr Opin Oncol. 2016.
    PubMed     Text format     Abstract available


  4. PAULITSCHKE V, Eichhoff O, Cheng PF, Levesque MP, et al
    Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma.
    Curr Opin Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2015
  5. DE UNAMUNO B, Palanca S, Botella R
    Update on melanoma epigenetics.
    Curr Opin Oncol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  6. DUMMER R, Goldinger SM, Paulitschke V, Levesque MP, et al
    Curing advanced melanoma by 2025.
    Curr Opin Oncol. 2015;27:125-7.
    PubMed     Text format     Abstract available


    January 2015
  7. AGARWALA SS
    Intralesional therapy for advanced melanoma: promise and limitation.
    Curr Opin Oncol. 2015.
    PubMed     Text format     Abstract available


  8. HEPPT MV, Tietze JK, Graf SA, Berking C, et al
    Combination therapy of melanoma using kinase inhibitors.
    Curr Opin Oncol. 2015.
    PubMed     Text format     Abstract available


  9. LEE B, Sandhu S, McArthur G
    Cell cycle control as a promising target in melanoma.
    Curr Opin Oncol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: